Head-to-head · Value Score
CoreAge Rx vs Navio MD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Navio MD a 75. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameNavio MD
#138 · Grade C+ · Fair Price
Est. first month
From $189/mo (compounded)
Save ~86% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Navio MD isn't out of it: Someone who wants tirzepatide specifically, or a brand-name Ozempic route on the same account.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Navio MD |
|---|---|---|
| Value Score | 93 (A+) | 75 (C+) |
| Est. first month | $99/mo | From $189/mo (compounded) |
| Save vs brand-name | ~89% | ~86% |
| Semaglutide | $99/mo | Not disclosed (compounded); brand Ozempic from $345/mo |
| Tirzepatide | $149/mo | From $189/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 48 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Navio MD
NavioMD sells compounded tirzepatide from $189 a month across 48 states, with brand-name Ozempic from $345 for anyone who wants semaglutide instead.
Why it's a deal
- Compounded tirzepatide from $189 is below the roughly $249 tirzepatide median tracked here
- Brand-name Ozempic is offered and priced openly at $345 rather than quoted after an intake
- Operates across 48 states and names the two it does not serve
- Treatment, provider access and delivery are handled in one flow with no separate membership
The fine print
- No compounded semaglutide at all — if you want semaglutide here it is brand-name at $345
- Not available in Alabama or Mississippi
- The advertised figures are "as low as" rates and the site does not publish what higher doses cost
- Women's hormone therapy sits alongside the weight program, so GLP-1s are one line rather than the focus
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Navio MD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.